Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population
Affiliation
Pharmacy Department, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2023
Metadata
Show full item recordAbstract
Background: This study aimed to develop a British version of the Patient Reported Outcomes for Fighting Financial Toxicity of Cancer (PROFFIT): originally designed to measure financial toxicity in cancer for an Italian universal healthcare system. The instrument was carefully evaluated for crosscultural equivalence, face validity and practicality. Methods: A systematic approach to cross-cultural adaptation was used, including forward translation, synthesis, backward translation, consolidation of translations with an expert committee, and cognitive interviews. As part of the cognitive interview process, 18 cancer patients completed a structured interview of 60-90 min in length. Results: The translated and modified PROFFIT questionnaire demonstrated good psycho-linguistic properties, including high compliance (only one item was revised for clarity), high retrieval from memory, high decision-making processes, and high response processes. Conclusion: PROFFIT has been found to be functional and adaptable in a new social environment. The tool may be useful for tailoring interventions to address and measure financial hardships within the cancer population, which appear to be a current challenge for public health. Policy summary: Even in universal healthcare systems, financial toxicity due to the increase in outof-pocket expenses poses a significant problem. The FT phenomenon warrants proper attention in the United Kingdom since it may negatively impact financial well-being, quality of life, psychosocial health, and treatment adherence.Citation
Patel A, Perrone F, Ashcroft DM, Flaum N, Cook N, Riva S. Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population. Journal of cancer policy. 2023 Aug 25;38:100440. PubMed PMID: 37633419. Epub 2023/08/27. eng.Journal
Journal of Cancer PolicyDOI
10.1016/j.jcpo.2023.100440PubMed ID
37633419Additional Links
https://doi.org/10.1016/j.jcpo.2023.100440Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jcpo.2023.100440
Scopus Count
Collections
Related articles
- Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
- Authors: Arenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Vaccaro MC, Frontini L, Giannarelli D, Bryce J, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F
- Issue date: 2023 Dec
- Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.
- Authors: Riva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L, Giannarelli D, Bryce J, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Jommi C, Vaccaro CM, Barberio D, Cinieri S, Porta C, Del Mastro L, Zagonel V, Cogoni AA, Bordonaro R, Gimigliano A, Piccirillo MC, Guizzaro L, Gallo C, Perrone F
- Issue date: 2021 Oct 20
- Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation.
- Authors: Benavent D, Jochems A, Pascual-Salcedo D, Jochems G, Plasencia-Rodríguez C, Ramiro S, van Lankveld W, Balsa A, Navarro-Compán V
- Issue date: 2023 Feb 13
- Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye.
- Authors: Santo RM, Ribeiro-Ferreira F, Alves MR, Epstein J, Novaes P
- Issue date: 2015 Apr
- Translation and cross-cultural adaption of the Chinese version of the Vanderbilt Head and Neck Symptom Survey version 2.0: a tool for oral symptom assessment in head and neck cancer patients.
- Authors: Jin M, Sun L, Meng R, Wang W, Sun R, Huang J, Qin Y, Wu B, Ding Q, Peng G, Zhang T, Yang K
- Issue date: 2021 Jan 21